CLOFARABINA VIVANTA 1mg / ml perfusive solution concentrate medication leaflet

L01BB06 clofarabine • Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues

Clofarabine is an antineoplastic agent used for the treatment of acute lymphoblastic leukemia in children and young adults who have not responded to other therapies. It works by inhibiting DNA and RNA synthesis in cancer cells, thereby preventing their proliferation.

The medication is administered intravenously, as directed by a doctor, usually as part of a treatment cycle. It is important for patients to undergo regular check-ups to monitor hematologic function and other effects of the therapy.

Patients should be aware of potential side effects, such as nausea, fever, or decreased blood cell counts. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, fever, and decreased blood cell counts. In rare cases, severe reactions such as liver failure or severe infections may occur. Patients should be informed of these risks before use.

General data about CLOFARABINA VIVANTA 1mg / ml

Substance: clofarabine

Date of last drug list: 01-06-2025

Commercial code: W65817001

Concentration: 1mg / ml

Pharmaceutical form: perfusive solution concentrate

Packing volume: 20 ml

Product type: generic

Price: 4229.88 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMADOX HEALTHCARE LTD. - MALTA

Holder: VIVANTA GENERICS S.R.O - REPUBLICA CEHA

Number: 15320/2024/01

Shelf life: Dupa ambalare pentru comercializare - 2 years; Dupa dilutie - it is used immediately

Pharmaceutical forms available for clofarabine

Compensation lists for CLOFARABINA VIVANTA 1mg / ml GENERICS

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

4229.88 RON

4229.88 RON

0.00 RON